Literature DB >> 7124713

A seroepidemiologic study of hepatitis B in a rural area in Israel.

Y Yodfat, W T London, P Whitford, Y Wax.   

Abstract

The prevalence rates of hepatitis B surface antigen (HBsAg), antibody to the surface antigen (anti-HBs), and antibody to the core antigen (anti-HBc) were studied in a rural population near Jerusalem in 1979-1980. Sera were systematically collected from 1411 individuals (33.0% of the total population) living in 10 villages populated by five Jewish ethnic groups (Cochins from India, Yemenites, Moroccans, Kurds from Iraq, and Ashkenazis). Evidence of existing or previous infection with hepatitis B virus was detected in 446 individuals (31.6%); of these, 3.3% were carriers of HBsAg, 24.1% were positive for anti-HBs, and 4.3% were positive for anti-HBc alone. Analysis in a log linear model revealed increasing hepatitis B virus infection with age and higher carrier rates among males. Hepatitis B virus infection was significantly lower among the Cochins and Ashkenazis, regardless of place of birth. Variation in the hepatitis B virus infection rate in the villages was completely accounted for by differences among the ethnic groups. These ethnic differences probably reflect the endemicity of hepatitis B virus infection in the various world regions from which the ethnic groups originate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7124713     DOI: 10.1093/oxfordjournals.aje.a113430

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  2 in total

1.  Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.

Authors:  G M Ginsberg; D Shouval
Journal:  J Epidemiol Community Health       Date:  1992-12       Impact factor: 3.710

2.  Hepatitis B virus markers in Japanese immigrants and their descendants in Bolivia and native Bolivians.

Authors:  H Sugimura; S Tsugane; S Watanabe; S Nanri; H Ishii
Journal:  Gastroenterol Jpn       Date:  1990-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.